SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001256088-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
34,597
Total Value
$1,202,807.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 5, 2026 | Sale | 10,000 | $53.71 | $537,100.00 | 28,159 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 7,905 | $25.30 | $199,996.50 | 36,064 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 6, 2026 | Sale | 8,787 | $53.00 | $465,711.00 | 27,277 | Direct | โ | View Details | |
Director | Director Stock Option (Right to Buy) | Derivative | Mar 6, 2026 | Exercise/Conversion | 7,905 | $0.00 | $0.00 | 0 | Direct | โ | View Details |